Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice

BACKGROUND: Artemisinin-based combination therapy (ACT) has been a mainstay for malaria prevention and treatment. However, emergence of drug resistance has incentivised development of new drugs. Defining the kinetics with which circulating parasitized red blood cells (pRBC) are lost after drug treat...

Descripción completa

Detalles Bibliográficos
Autores principales: SheelaNair, Arya, Romanczuk, Aleksandra S., Aogo, Rosemary A., Haldar, Rohit Nemai, Lansink, Lianne I. M., Cromer, Deborah, Salinas, Yandira G., Guy, R. Kiplin, McCarthy, James S., Davenport, Miles P., Haque, Ashraful, Khoury, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848794/
https://www.ncbi.nlm.nih.gov/pubmed/35172826
http://dx.doi.org/10.1186/s12936-022-04075-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848794/
https://www.ncbi.nlm.nih.gov/pubmed/35172826
http://dx.doi.org/10.1186/s12936-022-04075-z

Ejemplares similares